Omada Health is trading at $17.50, down 7.65% in pre-market on October 26, with no specific catalyst established.
- The latest listed company news was an October 20 research presentation.
- Q3 results are scheduled for November 5.
- Major indices are modestly higher in the supplied market context, so broad-market weakness does not explain the decline.